In situ electrochemiluminescence microneedle device for real-time biomarker monitoring in vivo.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41912545.
- Also identified by DOI 10.1038/s41467-026-70686-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Continuous in vivo monitoring of biomarkers remains challenging due to limited sensitivity, integration, and biocompatibility. Here, we report an integrated microneedle-based electrochemiluminescence device (MN-ECLD) for real-time detection of protein biomarkers in interstitial fluid. Leveraging hydrogen-bonded organic frameworks with ultrabright, biocompatible electrochemiluminescence, the emitters were incorporated into porous gold-coated microneedle arrays and regulated via interface-specific Y-shaped probes, enabling efficient coreactant-free signal generation. The device achieved ultrasensitive protein detection in vitro with a linear range of 100 fg/mL to 10 ng/mL, a detection limit of 21.3 fg/mL, and stability over 12 days, delivering an 87-fold sensitivity enhancement over conventional emitters. In vivo, MN-ECLD enabled real-time monitoring of cardiac biomarkers, achieving early warning of acute myocardial infarction in rats and pigs, with biomarker trends consistent with serum ELISA. This work establishes a versatile platform for continuous in vivo diagnostics of acute cardiovascular and metabolic disorders.